- Home
- STRO vs BCAL Comparison
STRO vs BCAL Comparison
Compare STRO & BCAL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | STRO | BCAL |
|---|---|---|
| Founded | 2003 | 2001 |
| Country | United States | United States |
| Employees | 133 | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 524.8M | 578.3M |
| IPO Year | N/A | 2020 |
Fundamental Metrics
Financial Performance| Metric | STRO | BCAL |
|---|---|---|
| Price | $25.43 | $18.99 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 9 | 3 |
| Target Price | ★ $31.33 | $20.67 |
| AVG Volume (30 Days) | ★ 255.3K | 138.5K |
| Earning Date | 05-11-2026 | 04-28-2026 |
| Dividend Yield | N/A | ★ 2.15% |
| EPS Growth | N/A | ★ 777.27 |
| EPS | N/A | ★ 0.42 |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $6.67 |
| P/E Ratio | ★ N/A | $45.26 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.67 | $14.07 |
| 52 Week High | $43.85 | $20.47 |
Technical Indicators
Market Signals| Indicator | STRO | BCAL |
|---|---|---|
| Relative Strength Index (RSI) | 30.61 | 56.39 |
| Support Level | $23.43 | $18.49 |
| Resistance Level | $27.96 | $19.26 |
| Average True Range (ATR) | 3.47 | 0.35 |
| MACD | -1.79 | -0.01 |
| Stochastic Oscillator | 0.40 | 68.09 |
Price Performance
Historical ComparisonAbout STRO Sutro Biopharma Inc.
Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers. Company's wholly-owned product candidate is STRO-004, a single homogeneous ADC directed against tissue factor which are developing for the treatment of solid tumors. The company also pipeline contains STRO-006, STRO-00X, STRO-00Y, STRO-003, VAX24, VAX31, and Others.
About BCAL Southern California Bancorp
California BanCorp is a registered bank holding company headquartered in San Diego, California. The Bank offers a range of financial products and services to individuals, professionals, and small to medium-sized businesses through its 14 branch offices and four loan production offices serving Northern and Southern California. The Bank's solutions-driven, relationship-based approach to banking provides accessibility to decision-makers and enhances value through partnerships with its clients. The company has one operating segment: Commercial Banking.